Syringe Pump Manufacturers Asked to Update Labeling

The GMP Letter
A A
The FDA has asked manufacturers of syringe pumps to update their labels to address flow continuity concerns that the agency identified as a serious risk to health.

To View This Article:

Login

Subscribe To The GMP Letter